The Pharma Letter2d
AbbVie opts in for first genetic medicine program with Capsida
Capsida Biotherapeutics yesterday revealed US pharma major AbbVie has exercised an option for the first neurodegenerative ...
FierceBiotech3d
AbbVie exercises first $40M option to advance Capsida-partnered CNS gene therapy
Gene therapy firm Capsida Biotherapeutics is advancing the first of its AbbVie-partnered neurodegenerative disease therapies ...
Le Lézard3d
QurAlis Invited to Present at 43rd Annual J.P. Morgan Healthcare Conference
QurAlis Corporation ("QurAlis"), a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that have the potential to alter the trajectory of ...
Le Lézard3d
Loan Intelligence Systems Unlock Untapped Revenue and Supercharge Small Business Lending ? New White Paper from Parlay Finance
Parlay Finance, a SaaS-based Loan Intelligence System (LIS) for credit unions and community banks issuing SBA and small business loans, today announced the availability of its white paper, ...
Capsida Announces AbbVie Opt-in for First Genetic Medicine Program from Neurodegenerative Disease Collaboration
Capsida Biotherapeutics ("Capsida") today announced that AbbVie has exercised an option for the first neurodegenerative ...